- Benefact number 872
Pharmacy-based Asymptomatic COVID-19 Testing Program Pilot - Benefact number 869
Alberta Drug Benefit List (ADBL) Interim Update now available online - Benefact number 868
Temporary benefits added to the Alberta Drug Benefit List (ADBL)
Temporary benefit removed from the Alberta Drug Benefit List (ADBL) - Benefact number 867
Influenza planning for the 2020/2021 season - Benefact number 865
Alberta Biosimilars Initiative Update
Year-end update on the Holdback Policy
Removal of temporary benefit from Alberta Human Services Drug Benefit
Supplement (HSDBS) - Benefact number 864
Product supply shortages addressed for Alberta Drug Benefit List (ADBL) - Benefact number 863
Update on measures to prevent drug product shortages
Information about products in a critical supply situation
Quantity authorization - Benefact number 862
Alberta Biosimilars Initiative Updates - Benefact number 861
Product supply shortages addressed for Alberta Drug Benefit List (ADBL) - Benefact number 860
Alberta Drug Benefit List (ADBL) Interim Update now available online
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Temporary benefit added to the Alberta Human Services Drug Benefit Supplement (HSDBS)
Product supply shortages addressed for Alberta Drug Benefit List (ADBL) - Benefact number 858
Importation of UK-Labelled Teva-Salamol CFC-Free (Salbutamol Sulfate) Inhaler due to Shortage
Temporary change to Step Therapy for Direct-Acting Oral Anticoagulants (DOACs) on the Alberta Drug Benefit List (ADBL) effective May 15, 2020 for government-sponsored programs - Benefact number 857
Declaration of a State of Local Emergency for Fort McMurray and surrounding area, and Mackenzie #23 Region, Alberta residents - Benefact number 855
Government coverage options for those impacted by COVID-19 - Benefact number 854
Alberta Biosimilar Initiative – update to switching timelines in response to COVID-19
Temporary access to Humira for Crohn’s Disease due to COVID-19 - Benefact number 853
Temporary benefit added to the Alberta Drug Benefit List (ADBL)
Temporary changes to coverage for Nicotine Products under the Alberta Human Services Drug Benefit Supplement
Changes to the Government of Alberta’s Palliative Coverage Program - Benefact number 852
Enhanced access to Opioid Agonist Therapy (OAT) - Benefact number 851
Manual Drug Claim forms—enhancement of submission process - Benefact number 850
Alberta Public Health Activities Program (APHAP) Influenza Immunization end of 2019/2020 season - Benefact number 848
Product supply shortage addressed for Alberta Drug Benefit List (ADBL)
Removal of temporary benefit from the Alberta Drug Benefit List (ADBL) - Benefact number 847
Updates regarding COVID-19 Pandemic - Benefact number 845
Updated Ministerial Order now available & Third quarter update on the Holdback policy - Benefact number 844
Alberta Health’s Coverage for Seniors program—income-based deductibles to be introduced in 2020 - Benefact number 843
Alberta Drug Benefit List (ADBL) Interim Update now available online as well as the Pan-Canadian Select Molecule Price Initiative for Generic Drugs - Benefact number 842
Reminder #2—Eligibility changes take effect March 1, 2020 to Alberta Health’s Coverage for Seniors Program. - Benefact number 841
Payment date change for AISH and Income Support - Benefact number 839
Reminder Eligibility changes to Coverage for Seniors Program - Benefact number 838
Alberta Drug Benefit List (ADBL) Interim Update now available online - Benefact number 837
Alberta Biosimilar Initiative—patient support letter and resources - Benefact number 836
Product supply shortages addressed for Alberta Drug Benefit List (ADBL) - Benefact number 835
Alberta Health’s Coverage for Seniors Program—eligibility changes effective March 1, 2020 - Benefact number 831
Calgary Catholic School District Group 14200-Drug Benefit Plan enhancements effective January 1, 2020 - Benefact number 830
Have you received and returned your First Amending Agreement? - Benefact number 827
Pharmacies supporting local schools for the Protection of Students with Life-threatening Allergies Act - Benefact number 826
Alberta Health announces an important change to coverage for biologic products under Alberta government sponsored programs - Benefact number 824
2019/2020 holiday hours schedule - Benefact number 823
Coverage criteria updates for select benefits of Government of Northwest Territories (GNWT) health benefit programs - Benefact number 822
Important reminder: Alberta Health’s change to coverage for select angiotensin-converting enzyme inhibitors (ACEIs), HMG-COA reductase inhibitors (statins) and calcium-channel blocking agents (CCBs) under Alberta government sponsored programs - Benefact number 821
Remember to share your feedback with our pharmacy provider survey! - Benefact number 818
Alberta Health announces an important change to coverage for select angiotensin-converting enzyme inhibitors (ACEIs), HMG-COA reductase inhibitors (statins) and calcium-channel blocking agents (CCBs) under Alberta government sponsored programs - Benefact number 817
Reopening of pharmacy provider survey Second quarter update on the Holdback Policy - Benefact number 816
Alberta Drug Benefit List (ADBL) Interim Update now available online - Benefact number 815
Alberta Blue Cross reminds pharmacies of the ability to obtain real-time authorizations for over 100-day medication supply - Benefact number 814
Alberta Public Health Activities Program (APHAP) Influenza Immunization Program 2019/2020 - Alberta Blue Cross Pharmacy Provider Survey
Alberta Blue Cross Pharmacy Provider Survey available online until September 27, 2019 - Benefact number 811
Alberta Blue Cross to administer prescription drug benefits for Ambrose/StudentVIP—Group 23710 - Benefact number 808
First quarter update on the Holdback Policy - Benefact number 804
Nazia Pharmacy termination notice - Benefact number 800
Ensuring Continuity of Care for Residents displaced by the Northwest Alberta wildfire - Benefact number 798
Alberta Blue Cross to administer prescription drug benefits for Rising Edge Technologies—Group 80931- SK&NF Pharmacy - Benefact number 797
Alberta Blue Cross to administer prescription drug benefits for Rising Edge Technologies—Group 80931 - Benefact number 794
Alberta Drug Benefit List (ADBL) Full Updates now available online - Benefact number 793
OHIP+Program Changes - Benefact number 791
Changes to the payment summary reconciliation reports - Benefact number 789
Pharmacy funding Framework - Benefact number 788
Update to the Insulin Pump Therapy (IPT) Program - Benefact number 785
Coverage criteria updates for select benefits of Government of Northwest Territories (GNWT) health benefit programs - Benefact number 782
Alberta Blue Cross to administer prescription drug benefits for Western Sales – Group 11419 - Benefact number 780
Alberta Blue Cross administering prescription drug benefits for two new groups effective January 1, 2019 - Benefact number 779
Service Alert – Planned POS System Outage and Temporary benefits added to the Alberta Drug Benefit List (ADBL) - Benefact number 777
Alberta Blue Cross administering prescription drug benefits for Engineered Air–group 80705 effective January 1, 2019 - Benefact number 776
Engineered Air and Edon Management Group 80705 - Benefact number 774
2018/2019 holiday hours schedule & 2019 payment schedule - Benefact number 772
Alberta Blue Cross Pharmaceutical Services Provider Agreement Compliance Verification Review process - Benefact number 771
Pneumococcal Polysaccharide 23-Valent Vaccine (Pneumo-P 23) added to the list of provincially funded vaccines for pharmacists - Benefact number 769
Diphtheria-Tetanus-Acellular Pertussis Combined Vaccine (dTap) added to the list of provincially-funded vaccines for pharmacists - Benefact number 765
Influenza Antiviral Drug Policy - Alberta Public Health Activities Program (APHAP) - Benefact number 764
Alberta Blue Cross has made it easier for pharmacies to obtain real-time claims submission authorization for over 100-day medication supply. - Benefact number 762
APHAP HIV Pre-Exposure Prophylaxis (PrEP) Program - Benefact number 757
Alberta Public Health Activities Program (APHAP) Influenza Immunization Program 2018/2019 - Benefact number 756
Blood Glucose Test Strip Limit for employer sponsored coverage - Benefact number 755
Update to greater than 100 days’ medication supply for ARTA - Benefact number 749
Update to greater than 100 days’ medication supply for the clients of the Government of Northwest Territories (GNWT) - Benefact number 741
Alberta Blue Cross Pharmaceutical Services Provider Agreement - Benefact number 740
Alberta Blue Cross Pharmaceutical Services Provider Agreement update #4 - Benefact number 739
Alberta Blue Cross Pharmaceutical Services Provider Agreement update #3 - Benefact number 734
Take Home Naloxone (THN) Program Update - Benefact number 733
Alberta Blue Cross Pharmaceutical Services Provider Agreement update #2 - Benefact number 732
Alberta Blue Cross Pharmaceutical Services Provider Agreement update #1 - Benefact number 730
Medical Assistance in Dying (MAID) drug program update - Benefact number 727
National Poison Prevention Week - Benefact number 725
Special Announcement: Pharmaceutical Services Provider Agreement - Benefact number 722
Pan-Canadian Pharmaceutical Alliance - Benefact number 717
Alberta Blue Cross to offer coverage for the FreeStyle Libre Flash Glucose Monitoring System for select group plans effective January 1, 2018 - Benefact number 715
Take Home Naloxone (THN) program update - Benefact number 714
Sunhills Mining LP- Group 9376 - Benefact number 712
2017/2018 holiday hours & 2018 Cheque Run Schedule - Benefact number 697
Drug Mifegymiso added to the Alberta Public Health Activities Program (APHAP) Women's Choice Program - Benefact number 695
Alberta Health Services adds products to QuitCore program (Group number 23699, Section A) - Benefact number 692
Coverage criteria updates for select benefits of Government of Northwest Territories (GNWT) health benefit programs - Benefact number 679
National Poison Prevention Week is March 19 to 25 - help to protect children from medication poisoning
Removal of temporary benefits from the Alberta Drug Benefit List (ADBL)
Product supply shortage addressed for Alberta Drug Benefit List (ADBL) - Benefact number 677
Pan-Canadian Competitive Value Price Initiative for Generic Drugs - Benefact number 673
Changes to allowable charges for nutritional products eligible under Government of Alberta-sponsored drug programs (updated February 22, 2017) - Benefact number 672
Naloxone update – Naloxone moves to unscheduled drug status and future Take Home Naloxone kits will include three vials of naloxone - Benefact number 670
Reminder: ARTA Retiree Benefits Plan change to coverage for proton pump inhibitors effective February 1, 2017 - Benefact number 668
Reminder #2-Alberta Health's change to coverage for proton pump inhibitors under Alberta government sponsored programs takes effect February 1 - Benefact number 662
Reminder #1-Alberta Health's change to coverage for proton pump inhibitors under Alberta government sponsored programs takes effect February 1 - Benefact number 654
2016/2017 holiday hours schedule and 2017 payment schedule - Benefact number 653
Alberta Blue Cross to administer prescription drug benefits for Lethbridge Family Services – Group 79716 - Benefact number 651
ARTA Retiree Benefits Plan – January 1, 2017 plan changes - Benefact number 650
Urgent notification – Electronic Funds Transfer payment summaries date error - Benefact number 646
Helping Alberta seniors to prevent falls - Alberta Blue Cross Pharmacy Provider Survey
Alberta Blue Cross Pharmacy Provider Survey available online until October 7, 2016 - Benefact number 644
Real Time authorizations over 100 days’ supply - Benefact number 633
Maintenance Medication Program (MMP) reminder - Benefact number 630
ASEBP introduces TARP, maintenance medication dispensing fee maximums and changes to Special Authorization renewals - Benefact number 627
Enhanced validation of correct prescriber identification numbers - Benefact number 623
Disruption of postal services - Benefact number 563
Notice to Alberta pharmacies regarding participation in the provision of Naloxone - Benefact number 612
Naloxone update-naloxone moves to Schedule 2 status - Benefact number 610
Reminder: emergency drug coverage for evacuated Fort McMurray, Alberta residents - Benefact number 607
Emergency drug coverage for evacuated Fort McMurray, Alberta residents - Benefact number 596
Alberta Blue Cross to administer prescription drug benefits for The Banff Centre – Group 79321 - Benefact number 585
Maintenance Medication Program (MMP)
MMP editing effective March 1, 2016 - Benefact number 581
Unit of Issue changes form “cartridge” to “dose” - Benefact number 578
Alberta Drug Benefit List (ABDL) Interim Update Now Available Online - Benefact number 576
Explore the pharmacy providers section of the Alberta Blue Cross web site for additional resources - Benefact number 575
Update on the Naloxone Program - Benefact number 574
Generic pricing changes introduced for most private plans - Benefact number 569
Important information to assist with submitting manual Drug Claim Forms - Benefact number 567
2015/2016 holiday hours schedule and 2016 payment schedule - Benefact number 560
Alberta Health Insulin Pump Therapy Program claiming tips - Benefact number 557
ASEBP Enhanced Special Authorization Process Update - Benefact number 555
Alberta Public Health Activities Program (APHAP) - Benefact number 549
Alberta Public Health Activities Program (APHAP) - Benefact number 548
Eligibility guidelines for topical diclofenac compounds - Benefact number 540
Alberta School Employee Benefit Plan (ASEBP)— September 1, 2015 - Benefact number 536
Preferred Provider Networks (PPN) or providing discounts on prescription drugs - Benefact number 535
Enhancing the coordination of benefits adjudication process - Medavie Blue Cross processing Federal claims
Effective Jan. 19, 2015, Medavie will be processing all online and paper pharmacy/drug claims for all regions in Canada - Pharmacy Provider Website
Additional resources now available on the Alberta Blue Cross web site
To protect the security of personal information, your Internet browser will need to be upgraded to access this website. Please ensure you use the latest version of:
Internet Explorer
Microsoft Edge
Mozilla Firefox
Google Chrome
Safari